Fluvoxamine for Early Treatment of COVID-19: What You Should Know
from Washington University in St. Louis What did we find? Adults recently diagnosed with COVID-19 (less than 7 days) who took fluvoxamine for up to 15 days, did not show clinical deterioration. Clinical deterioration is the combination of shortness of breath and hypoxia (decrease in oxygen), which are signs of damage to the lungs. This …
Fluvoxamine for Early Treatment of COVID-19: What You Should Know Read More »